|
Diabetes, Vol 49, Issue 4 618-625, Copyright © 2000 by American Diabetes Association
v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats
VH Maier, DR Melvin, CA Lister, H Chapman, GW Gould and GJ Murphy
Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Scotland, UK.
Insulin stimulation of adipose and muscle cells results in the
translocation of GLUT4 from an intracellular location to the plasma
membrane; this translocation is defective in insulin resistance. Studies
have suggested an important role for synaptobrevin and syntaxin homologues
in this event, particularly the v-soluble N-ethylmaleimide attachment
protein receptors (SNAREs) cellubrevin and vesicle-associated membrane
protein-2 (VAMP-2) and the t-SNARE syntaxin 4, but the expression of these
proteins has not been studied in insulin-resistant tissues. Therefore, we
examined SNARE protein content in skeletal muscle from Zucker diabetic
fatty (ZDF) rats compared with lean controls and determined the effect of
the thiazolidinedione insulin sensitizer rosiglitazone on these proteins.
GLUT4 levels in skeletal muscle from ZDF rats were similar to those in lean
control animals. In contrast, cellubrevin, VAMP-2, and syntaxin 4 protein
levels were elevated (2.8-fold, P = 0.02; 3.7-fold, P = 0.01; and 2.2-fold,
P < 0.05, respectively) in skeletal muscle from ZDF rats compared with
lean controls. Restoration of normoglycemia and normoinsulinemia in ZDF
rats with rosiglitazone (30 micromol/kg) normalized cellubrevin, VAMP-2,
and syntaxin 4 protein to levels approaching those observed in lean control
animals. These data show that elevated v- and t-SNARE protein levels are
associated with insulin resistance in skeletal muscle and that these
increases may be reversed by rosiglitazone treatment concomitant with a
restoration of glycemic control. Such increases in SNARE protein levels
were not observed in streptozotocin-induced diabetic rats, which suggests
that hyperinsulinemia rather than hyperglycemia may be more important in
modulating SNARE protein expression in rodent models of insulin resistance.
Consistent with this hypothesis, elevated levels of SNARE proteins were
also observed in 3T3-L1 adipocytes chronically treated with insulin (500
nmol/l for 24 h). These data argue that SNARE protein levels may be altered
in insulin-resistant states and that the levels of these proteins are
modulated by agents that increase insulin sensitivity. Moreover, these data
demonstrate for the first time altered expression of proteins known to
regulate GLUT4 translocation in a model of diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Ragolia, T. Palaia, C. E. Hall, J. K. Maesaka, N. Eguchi, and Y. Urade
Accelerated Glucose Intolerance, Nephropathy, and Atherosclerosis in Prostaglandin D2 Synthase Knock-out Mice
J. Biol. Chem.,
August 19, 2005;
280(33):
29946 - 29955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Spurlin, S.-Y. Park, A. K. Nevins, J. K. Kim, and D. C. Thurmond
Syntaxin 4 Transgenic Mice Exhibit Enhanced Insulin-Mediated Glucose Uptake in Skeletal Muscle
Diabetes,
September 1, 2004;
53(9):
2223 - 2231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Maier and A. Olek
Diabetes: A Candidate Disease for Efficient DNA Methylation Profiling
J. Nutr.,
August 1, 2002;
132(8):
2440S - 2443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Jucker, T. R. Schaeffer, R. E. Haimbach, T. S. McIntosh, D. Chun, M. Mayer, D. H. Ohlstein, H. M. Davis, S. A. Smith, A. R. Cobitz, et al.
Normalization of Skeletal Muscle Glycogen Synthesis and Glycolysis in Rosiglitazone-Treated Zucker Fatty Rats: An In Vivo Nuclear Magnetic Resonance Study
Diabetes,
July 1, 2002;
51(7):
2066 - 2073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kubota, A. Kobayashi, N. Mori, T. Higashide, M. J. McLaren, and G. Inana
Changes in Retinal Synaptic Proteins in the Transgenic Model Expressing a Mutant HRG4 (UNC119)
Invest. Ophthalmol. Vis. Sci.,
February 1, 2002;
43(2):
308 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. James, F. Cairns, I. P. Salt, G. J. Murphy, A. F. Dominiczak, J. M.C. Connell, and G. W. Gould
Skeletal Muscle of Stroke-Prone Spontaneously Hypertensive Rats Exhibits Reduced Insulin-Stimulated Glucose Transport and Elevated Levels of Caveolin and Flotillin
Diabetes,
September 1, 2001;
50(9):
2148 - 2156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Foster and A. Klip
Mechanism and regulation of GLUT-4 vesicle fusion in muscle and fat cells
Am J Physiol Cell Physiol,
October 1, 2000;
279(4):
C877 - C890.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Diabetes Association.
|
|
| |
|